Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors as of Dec. 31, 2020

Portfolio Holdings for Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors holds 26 positions in its portfolio as reported in the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Springworks Therapeutics (SWTX) 33.2 $528M 7.3M 72.52
Atea Pharmaceuticals (AVIR) 14.7 $235M 5.6M 41.78
Arcutis Biotherapeutics (ARQT) 7.0 $112M 4.0M 28.13
Mersana Therapeutics (MRSN) 5.8 $92M 3.4M 26.61
Annexon (ANNX) 5.1 $81M 3.2M 25.03
Dicerna Pharmaceuticals 4.3 $68M 3.1M 22.03
Syros Pharmaceuticals 3.9 $63M 5.8M 10.85
C4 Therapeutics Com Stk (CCCC) 3.4 $54M 1.6M 33.13
Solid Biosciences 3.4 $54M 7.1M 7.58
Dynavax Technologies Corp option 3.0 $49M 11M 4.45
Nurix Therapeutics (NRIX) 2.7 $42M 1.3M 32.88
Constellation Pharmceticls I 2.5 $40M 1.4M 28.80
Aptinyx 1.9 $31M 8.9M 3.46
Kymera Therapeutics (KYMR) 1.9 $30M 480k 62.00
Aeglea Biotherapeutics 1.3 $21M 2.7M 7.87
Marinus Pharmaceuticals 1.1 $18M 1.4M 12.20
Crinetics Pharmaceuticals In (CRNX) 0.9 $15M 1.1M 14.11
Therapeutics Acquisition Cor Com Cl A 0.9 $14M 1.0M 13.92
Arya Sciences Acquisition Corp Iii Com Cl A 0.7 $11M 1.0M 10.85
X4 Pharmaceuticals (XFOR) 0.7 $11M 1.6M 6.43
Savara (SVRA) 0.4 $5.9M 5.1M 1.15
Bctg Acquisition Corp 0.4 $5.7M 500k 11.44
Bcls Acquisition Corp Com Cl A 0.3 $5.4M 488k 11.14
Frazier Lifesciences Acquisition Corp Unit 12/09/2025 0.2 $3.1M 300k 10.38
Jiya Acquisition Corp Com Cl A 0.2 $3.1M 300k 10.30
Helix Acquisition Corp Com Cl A 0.2 $2.8M 250k 11.37